ATENOLOL\NIFEDIPINE: 27 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
27
Total FAERS Reports
1 (3.7%)
Deaths Reported
17
Hospitalizations
27
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20060118 · Latest Report: 20200623
What Are the Most Common ATENOLOL\NIFEDIPINE Side Effects?
#1 Most Reported
Fall
9 reports (33.3%)
#2 Most Reported
Vertigo
6 reports (22.2%)
#3 Most Reported
Malaise
6 reports (22.2%)
All ATENOLOL\NIFEDIPINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fall | 9 | 33.3% | 0 | 9 |
| Aortic valve incompetence | 6 | 22.2% | 0 | 0 |
| Arrhythmia | 6 | 22.2% | 0 | 0 |
| Bradycardia | 6 | 22.2% | 0 | 0 |
| Cerebral haematoma | 6 | 22.2% | 0 | 6 |
| Dizziness | 6 | 22.2% | 0 | 0 |
| Malaise | 6 | 22.2% | 0 | 0 |
| Vertigo | 6 | 22.2% | 0 | 0 |
| Aortic valve sclerosis | 5 | 18.5% | 0 | 0 |
| Atrial fibrillation | 5 | 18.5% | 0 | 0 |
| Hypertensive cardiomyopathy | 5 | 18.5% | 0 | 0 |
| Mitral valve incompetence | 5 | 18.5% | 0 | 0 |
| Tricuspid valve incompetence | 5 | 18.5% | 0 | 0 |
Who Reports ATENOLOL\NIFEDIPINE Side Effects? Age & Gender Data
Gender: 39.3% female, 60.7% male. Average age: 77.2 years. Most reports from: FR. View detailed demographics →
Is ATENOLOL\NIFEDIPINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 1 | 1 | 0 |
| 2007 | 6 | 0 | 0 |
| 2013 | 1 | 0 | 0 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 6 | 0 | 6 |
| 2018 | 8 | 0 | 8 |
| 2020 | 1 | 0 | 0 |
What Is ATENOLOL\NIFEDIPINE Used For?
| Indication | Reports |
|---|---|
| Hypertension | 22 |
Official FDA Label for ATENOLOL\NIFEDIPINE
Official prescribing information from the FDA-approved drug label.